Issue
Federal Register Volume 82 Issue 228 (Wednesday, November 29, 2017)
This issue includes canonical document pages and full document metadata.
COMMISSION ON CIVIL RIGHTS
DEPARTMENT OF AGRICULTURE Animal and Plant Health Inspection Service
DEPARTMENT OF COMMERCE Bureau of Industry and Security
- Impact of the Implementation of the Chemical Weapons Convention (CWC) on Legitimate Commercial Chemical, Biotechnology, and Pharmaceutical Activities Involving “Schedule 1” Chemicals (Including Schedule 1 Chemicals Produced as Intermediates) Through Calendar Year 2017
- Impact of the Implementation of the Chemical Weapons Convention (CWC) on Legitimate Commercial Chemical, Biotechnology, and Pharmaceutical Activities Involving “Schedule 1” Chemicals (Including Schedule 1 Chemicals Produced as Intermediates) Through Calendar Year 2017
DEPARTMENT OF COMMERCE International Trade Administration
DEPARTMENT OF COMMERCE National Oceanic and Atmospheric Administration
- Fisheries of the Exclusive Economic Zone Off Alaska; Several Groundfish Species in the Bering Sea and Aleutian Islands Management Area
- Fisheries of the Exclusive Economic Zone Off Alaska; Several Groundfish Species in the Bering Sea and Aleutian Islands Management Area
- New England Fishery Management Council; Public Meeting
- New England Fishery Management Council; Public Meeting
- Pacific Fishery Management Council; Public Meeting (Webinar)
- Pacific Fishery Management Council; Public Meeting (Webinar)
DEPARTMENT OF ENERGY Federal Energy Regulatory Commission
- Northwest Pipeline, LLC; Supplemental Notice of Intent To Prepare an Environmental Assessment for the Amended North Seattle Lateral Upgrade Project and Request for Comments on Environmental Issues
- Northwest Pipeline, LLC; Supplemental Notice of Intent To Prepare an Environmental Assessment for the Amended North Seattle Lateral Upgrade Project and Request for Comments on Environmental Issues
- Notice of Electric Quarterly Report Users Group Meeting
- Notice of Electric Quarterly Report Users Group Meeting
- Southern Star Central Gas Pipeline, Inc.; Notice of Request Under Blanket Authorization
- Southern Star Central Gas Pipeline, Inc.; Notice of Request Under Blanket Authorization
- City of Kaukauna, Wisconsin; Notice of Application Accepted for Filing, Soliciting Motions To Intervene and Protests, Ready for Environmental Analysis, and Soliciting Comments, Recommendations, Terms and Conditions, and Prescriptions
- City of Kaukauna, Wisconsin; Notice of Application Accepted for Filing, Soliciting Motions To Intervene and Protests, Ready for Environmental Analysis, and Soliciting Comments, Recommendations, Terms and Conditions, and Prescriptions
- Blue Mountain Midstream LLC; Notice of Application
- Blue Mountain Midstream LLC; Notice of Application
- City Water and Light Plant of the City of Jonesboro; Notice of Filing
- City Water and Light Plant of the City of Jonesboro; Notice of Filing
- Occidental Energy Marketing, Inc. v. BridgeTex Pipeline Company, LLC; Notice of Complaint
- Occidental Energy Marketing, Inc. v. BridgeTex Pipeline Company, LLC; Notice of Complaint
- Combined Notice of Filings #1
- Combined Notice of Filings #1
- Western Area Power Administration; Notice of Filing
- Western Area Power Administration; Notice of Filing
- RH energytrans, LLC; Notice of Intent To Prepare an Environmental Assessment for the Proposed Risberg Line Project, and Request for Comments on Environmental Issues
- RH energytrans, LLC; Notice of Intent To Prepare an Environmental Assessment for the Proposed Risberg Line Project, and Request for Comments on Environmental Issues
DEPARTMENT OF HEALTH AND HUMAN SERVICES
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
- Determination of Regulatory Review Period for Purposes of Patent Extension; XURIDEN
- Determination of Regulatory Review Period for Purposes of Patent Extension; XURIDEN
- Roxane Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for ROXICODONE (Oxycodone Hydrochloride) Sustained-Release Tablets, 10 Milligrams and 30 Milligrams
- Roxane Laboratories, Inc.; Withdrawal of Approval of a New Drug Application for ROXICODONE (Oxycodone Hydrochloride) Sustained-Release Tablets, 10 Milligrams and 30 Milligrams
- Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
- Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications for Manufacturers of In Vitro Diagnostic Devices; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
- Determination of Regulatory Review Period for Purposes of Patent Extension; VELTASSA
- Determination of Regulatory Review Period for Purposes of Patent Extension; VELTASSA
- Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
- Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
- Determination of Regulatory Review Period for Purposes of Patent Extension; REXULTI
- Determination of Regulatory Review Period for Purposes of Patent Extension; REXULTI
- Determination of Regulatory Review Period for Purposes of Patent Extension; SOLX SYSTEM
- Determination of Regulatory Review Period for Purposes of Patent Extension; SOLX SYSTEM
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Recordkeeping and Reporting Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing Material From Cattle
- Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Recordkeeping and Reporting Requirements for Human Food and Cosmetics Manufactured From, Processed With, or Otherwise Containing Material From Cattle
DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration
- Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: NURSE Corps Scholarship Program, OMB No. 0915-0301-Revision
- Agency Information Collection Activities: Proposed Collection: Public Comment Request; Information Collection Request Title: NURSE Corps Scholarship Program, OMB No. 0915-0301-Revision
- Agency Information Collection Activities: Proposed Collection: Public Comment Request Information Collection Request Title: Health Professions Student Loan (HPSL) Program and Nursing Student Loan (NSL) Program Administrative Requirements (Regulations and Policy). OMB No. 0915-0047-Revision
- Agency Information Collection Activities: Proposed Collection: Public Comment Request Information Collection Request Title: Health Professions Student Loan (HPSL) Program and Nursing Student Loan (NSL) Program Administrative Requirements (Regulations and Policy). OMB No. 0915-0047-Revision
DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health
- Prospective Grant of an Exclusive Patent License: Concatenated L2 Peptide Based Human Papillomavirus Vaccines
- Prospective Grant of an Exclusive Patent License: Concatenated L2 Peptide Based Human Papillomavirus Vaccines
- Prospective Grant of Exclusive Patent License: T-Cells Transduced with HLA A11 Restricted CT-RCC HERV-E Reactive T-Cell Receptors for the Treatment of Renal Cell Carcinoma
- Prospective Grant of Exclusive Patent License: T-Cells Transduced with HLA A11 Restricted CT-RCC HERV-E Reactive T-Cell Receptors for the Treatment of Renal Cell Carcinoma
- Prospective Grant of Exclusive Patent Commercialization License: N6, A Novel, Broad, Highly Potent HIV-Specific Antibody
- Prospective Grant of Exclusive Patent Commercialization License: N6, A Novel, Broad, Highly Potent HIV-Specific Antibody
- National Center for Advancing Translational Sciences; Notice of Meetings
- National Center for Advancing Translational Sciences; Notice of Meetings
- National Institute on Aging; Notice of Closed Meeting
- National Institute on Aging; Notice of Closed Meeting
- National Heart, Lung, and Blood Institute; Notice of Closed Meeting
- National Heart, Lung, and Blood Institute; Notice of Closed Meeting
DEPARTMENT OF HOMELAND SECURITY Coast Guard
DEPARTMENT OF LABOR Employee Benefits Security Administration
- 18-Month Extension of Transition Period and Delay of Applicability Dates; Best Interest Contract Exemption (PTE 2016-01); Class Exemption for Principal Transactions in Certain Assets Between Investment Advice Fiduciaries and Employee Benefit Plans and IRAs (PTE 2016-02); Prohibited Transaction Exemption 84-24 for Certain Transactions Involving Insurance Agents and Brokers, Pension Consultants, Insurance Companies, and Investment Company Principal Underwriters (PTE 84-24)
- 18-Month Extension of Transition Period and Delay of Applicability Dates; Best Interest Contract Exemption (PTE 2016-01); Class Exemption for Principal Transactions in Certain Assets Between Investment Advice Fiduciaries and Employee Benefit Plans and IRAs (PTE 2016-02); Prohibited Transaction Exemption 84-24 for Certain Transactions Involving Insurance Agents and Brokers, Pension Consultants, Insurance Companies, and Investment Company Principal Underwriters (PTE 84-24)
- Claims Procedure for Plans Providing Disability Benefits; 90-Day Delay of Applicability Date
- Claims Procedure for Plans Providing Disability Benefits; 90-Day Delay of Applicability Date